Towards Healthcare Research & Consulting
Cell and Gene Therapy Drug Delivery Devices Market
Updated Date: 02 April 2026   |   Report Code: 6096
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Cell and Gene Therapy Drug Delivery Devices Market Accelerates Advanced Therapy Adoption

Cell and Gene Therapy Drug Delivery Devices Market ( By Product / Device Type: Infusion Systems & Pumps, Prefilled Syringes & Vials, Autoinjectors & Wearable Injectors, Apheresis & Collection Kits / Administration Kits, Closed System Transfer Devices (CSTDs) & Sterile Connectors, Catheters, Delivery Needles & Localized Delivery Devices, Ancillary & Packaging Devices; By Therapy Type / Use Case, Autologous Cell Therapy Administration, Allogeneic Off-the-Shelf Products, Intrathecal, intramuscular, intravitreal, and intratumoral delivery devices; By Delivery Route: Intravenous / Intracavitary Infusion, Subcutaneous, Intrathecal / Intracerebral, Intramuscular / Intravitreal / Intratumoral; By End User: Hospitals & Specialty Clinics, Ambulatory & Home Infusion, CDMOs & GMP Manufacturing Sites, Research & Academic Hospitals, Retail / Specialty Pharmacies; By Technology / Features: Single-use, Closed-system Technologies, Wearable, On-body High-volume Injectors, Smart/Connected Devices, Needle-free / Minimally Invasive Delivery, Sterile Weld/Connector Technologies; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035.

Last Updated : 02 April 2026 Category: Medical Devices Insight Code: 6096 Format: PDF / PPT / Excel

Content

Global Cell and Gene Therapy Drug Delivery Devices Market

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 1
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 2
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 3
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Drug Delivery Devices Market Analysis
  • North America Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • S. Cell and Gene Therapy Drug Delivery Devices Market Analysis
    • S. Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Cell and Gene Therapy Drug Delivery Devices Market Analysis, By Segment 3, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Baxter International
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

    • Becton, Dickinson & Company (BD)
    • B. Braun Melsungen
    • Terumo Corporation
    • Medtronic
    • ICU Medical
    • West Pharmaceutical Services
    • Stevanato Group
    • Gerresheimer
    • Ypsomed
    • SHL Medical / Enable Injections
    • Catalent Pharma Solutions
    • Sartorius
    • Thermo Fisher Scientific
    • Lonza
    • Miltenyi Biotec
    • Fresenius Kabi
    • Peli BioThermal
    • Sagent Pharmaceuticals / Nemera
    • Corin / Catheter & micro-delivery specialists/niche OEMs

FAQ's

Answer : The cell and gene therapy drug delivery devices market is expected to cross US$ 1.33 billion in 2026, and is projected to hit US$ 3.3 billion by 2035, growing at a CAGR of 10.64%.

Answer : Baxter International, Becton, Dickinson & Company, Medtronic, Terumo Corporation, Lonza.

Answer : Expansion of single-use, closed-system technologies to reduce contamination risks, Rapid adoption of wearable, on-body high-volume injectors, Growth of decentralized and home-based therapy administration.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar